313 related articles for article (PubMed ID: 30462668)
1. Differential roles of gangliosides in malignant properties of melanomas.
Ohmi Y; Kambe M; Ohkawa Y; Hamamura K; Tajima O; Takeuchi R; Furukawa K; Furukawa K
PLoS One; 2018; 13(11):e0206881. PubMed ID: 30462668
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3.
Shibuya H; Hamamura K; Hotta H; Matsumoto Y; Nishida Y; Hattori H; Furukawa K; Ueda M; Furukawa K
Cancer Sci; 2012 Sep; 103(9):1656-64. PubMed ID: 22632091
[TBL] [Abstract][Full Text] [Related]
3. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
[TBL] [Abstract][Full Text] [Related]
4. GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line.
Dong Y; Ikeda K; Hamamura K; Zhang Q; Kondo Y; Matsumoto Y; Ohmi Y; Yamauchi Y; Furukawa K; Taguchi R; Furukawa K
Cancer Sci; 2010 Sep; 101(9):2039-47. PubMed ID: 20594196
[TBL] [Abstract][Full Text] [Related]
5. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.
Livingston PO; Ritter G; Calves MJ
Cancer Immunol Immunother; 1989; 29(3):179-84. PubMed ID: 2731184
[TBL] [Abstract][Full Text] [Related]
6. Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3.
Ohkawa Y; Miyazaki S; Miyata M; Hamamura K; Furukawa K; Furukawa K
Biochem Biophys Res Commun; 2008 Aug; 373(1):14-9. PubMed ID: 18538130
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
Hersey P
Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856
[TBL] [Abstract][Full Text] [Related]
9. Gangliosides of human melanoma.
Tsuchida T; Saxton RE; Morton DL; Irie RF
J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of melanoma-associated gangliosides in cancer patients.
Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.
Yesmin F; Bhuiyan RH; Ohmi Y; Yamamoto S; Kaneko K; Ohkawa Y; Zhang P; Hamamura K; Cheung NV; Kotani N; Honke K; Okajima T; Kambe M; Tajima O; Furukawa K; Furukawa K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008849
[TBL] [Abstract][Full Text] [Related]
12. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.
Hoon DS; Irie RF; Cochran AJ
Cell Immunol; 1988 Feb; 111(2):410-9. PubMed ID: 3123073
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gangliosides in human uveal melanoma cells.
Soulieres D; Rousseau A; Deschenes J; Tremblay M; Tardif M; Pelletier G
Int J Cancer; 1991 Oct; 49(4):498-503. PubMed ID: 1917148
[TBL] [Abstract][Full Text] [Related]
16. B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2.
Yoshida H; Koodie L; Jacobsen K; Hanzawa K; Miyamoto Y; Yamamoto M
Sci Rep; 2020 Jan; 10(1):1199. PubMed ID: 31988291
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells.
Hamamura K; Tsuji M; Ohkawa Y; Nakashima H; Miyazaki S; Urano T; Yamamoto N; Ueda M; Furukawa K; Furukawa K
Biochim Biophys Acta; 2008 Mar; 1780(3):513-9. PubMed ID: 18078823
[TBL] [Abstract][Full Text] [Related]
18. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells.
Ruan S; Raj BK; Lloyd KO
J Neurochem; 1999 Feb; 72(2):514-21. PubMed ID: 9930722
[TBL] [Abstract][Full Text] [Related]
19. Disialyl gangliosides enhance tumor phenotypes with differential modalities.
Furukawa K; Hamamura K; Ohkawa Y; Ohmi Y; Furukawa K
Glycoconj J; 2012 Dec; 29(8-9):579-84. PubMed ID: 22763744
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.
Hamamura K; Furukawa K; Hayashi T; Hattori T; Nakano J; Nakashima H; Okuda T; Mizutani H; Hattori H; Ueda M; Urano T; Lloyd KO; Furukawa K
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11041-6. PubMed ID: 16040804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
